SUITABILITY OF THE DOG AS AN ANIMAL-MODEL FOR EVALUATING THEOPHYLLINE ABSORPTION AND FOOD EFFECTS FROM DIFFERENT FORMULATIONS

被引:19
作者
COOK, CS
HAUSWALD, CL
GRAHN, AY
KOWALSKI, K
KARIM, A
KOCH, R
SCHOENHARD, GL
OPPERMANN, JA
机构
[1] Department of Drug Metabolism G.D. Searle and Co, Skokie, IL 60077
关键词
Animal model; Bioavailability; Controlled-release formulation; Food effect; Theophylline;
D O I
10.1016/0378-5173(90)90297-H
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
This study evaluates the absorption of theophylline in humans and dogs from formulations exhibiting differences in in vitro dissolution profiles under fasting conditions. In addition, food-induced changes in the kinetics of absorption of theophylline from different formulations were examined. After administration of three experimental controlled-release (CR) formulations under fasting conditions, the directions of changes in the rate and extent of theophylline absorption found in the dog were similar to those determined in humans. Furthermore, food-induced changes in the rate and extent of absorption found in humans were confirmed in the dog. It is concluded that the dog is a suitable animal model for assessing the absorption characteristics and food effects with different formulations of theophylline. © 1990.
引用
收藏
页码:125 / 132
页数:8
相关论文
共 21 条
[1]
BIOAVAILABILITY OF GRISEOFULVIN FROM TABLETS IN BEAGLE DOGS AND CORRELATION WITH DISSOLUTION RATE AND BIOAVAILABILITY IN HUMANS [J].
AOYAGI, N ;
OGATA, H ;
KANIWA, N ;
KOIBUCHI, M ;
SHIBAZAKI, T ;
EJIMA, A ;
TAMAKI, N ;
KAMIMURA, H ;
KATOUGI, Y ;
OMI, Y .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (10) :1169-1172
[2]
COCHRAN WG, 1957, EXPT DESIGN, P203
[3]
GILL JL, 1978, DESIGN ANAL EXPT ANI, V2, P32
[4]
AVOIDANCE OF ADVERSE-EFFECTS DURING CHRONIC THERAPY WITH THEOPHYLLINE [J].
HENDELES, L ;
WEINBERGER, M .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1980, 14 (7-8) :522-530
[5]
HENDELES L, 1985, AM PHARM N, V525, P592
[6]
HENDELES L, 1985, CHEST, V87, P592
[7]
COMPARATIVE PHARMACOKINETIC EVALUATION OF SUSTAINED-RELEASE THEOPHYLLINE FORMULATIONS IN DOGS AND HUMANS [J].
HUSSEIN, Z ;
BIALER, M ;
FRIEDMAN, M ;
RAZ, I .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1987, 37 (1-2) :97-102
[8]
Karim A, 1985, Am Pharm, VNS25, P4
[10]
FOOD-INDUCED CHANGES IN THEOPHYLLINE ABSORPTION FROM CONTROLLED-RELEASE FORMULATIONS .2. IMPORTANCE OF MEAL COMPOSITION AND DOSING TIME RELATIVE TO MEAL INTAKE IN ASSESSING CHANGES IN ABSORPTION [J].
KARIM, A ;
BURNS, T ;
JANKY, D ;
HURWITZ, A .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (06) :642-647